NH legalization bill to conference; Congressional marijuana & psychedelics amendments; Study: cannabis terpenes treat pain; FL ballot endorsement Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana... Read more
The governor of New Jersey says he’s “honored” to have a marijuana product named after him, and he wants to build upon the state’s legalization law to provide “more equity, more reward and redemption” for people impacted under prohibition. During a tour of a cannabis cultivation facility this week,... Read more
“I believe an unregulated product like this, which clearly has caused some health problems, ought to be regulated by the state.” By Catrina Petersen, The Center Square The sponsor of a measure to regulate Illinois’s hemp industry says children are overdosing on cannabinoid products derived from hemp and it... Read more
When a House committee approved an amendment to a large-scale agriculture bill last week that would effectively ban most consumable hemp products, it was met with an atypically mixed response from the cannabis industry. Even within trade associations that supported the amendment to the 2024 Farm Bill, such as... Read more
The governor of Florida is reportedly planning to veto a bill that would ban consumable hemp-derived cannabinoid products such as delta-8 THC, apparently because he’s hoping the hemp industry will help finance a campaign opposing a marijuana legalization initiative on the state’s November ballot. As Gov. Ron DeSantis (R)... Read more
Vermont Gov. Phil Scott (R) this week signed a bill into law to create a psychedelic-assisted therapy working group that will make recommendations on whether and how the state should regulate legal access to substances such as psilocybin and MDMA. The governor vetoed separate legislation, however, that would have... Read more
Cannabis stocks, as measured by the Global Cannabis Stock Index, exploded higher in late August on news that the Department of Health and Human Services had recommended to the DEA that it move cannabis from Schedule 1 to Schedule 3, and the move continued into September. October wiped out the... Read more
As we described in a previous article, the Global Cannabis Stock Index sank in May, falling 14.6%. It is now up 44.4% in 2024. In this article, we summarize the performance of the other managed indices that New Cannabis Ventures offers to its readers. We discuss the performance of the American Cannabis Operator... Read more
